Skip to main content

Published locations for Ibrutinib and bortezomib combo durably effective in relapsed or refractory MCL with high-risk features

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib and bortezomib combo durably effective in relapsed or refractory MCL with high-risk features

User login

  • Reset your password
  • /content/ibrutinib-and-bortezomib-combo-durably-effective-relapsed-or-refractory-mcl-high-risk
  • /b-cell-lymphoma-icymi/article/266058/b-cell-lymphoma/ibrutinib-and-bortezomib-combo-durably